- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06923748
Comparison of Two Interdental Devices for Peri-Implant Plaque Control
November 21, 2025 updated by: Nicola Discepoli, University of Siena
Comparison of Two Different Interproximal Cleaning Devices Around Dental Implants: A Randomized Clinical Trial
This randomized clinical trial aims to compare the efficacy of two interproximal cleaning devices-superfloss and interdental brushes- in patients diagnosed with peri-implant diseases.
The study evaluates plaque control and bleeding scores.
Patients will be randomly assigned to one of two oral hygiene protocols and will be monitored through clinical examinations and validated questionnaires assessing both clinical and radiographic parameters and patient-reported outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This single-center, randomized, parallel-arm clinical trial aims to compare the efficacy of superfloss and interdental brushes, used in combination with an electronic toothbrush, in patients with peri-implant diseases.
Participants will be randomly assigned to one of two oral hygiene protocols.
Clinical assessments will be performed at baseline, 6 weeks, and 3 months, including plaque index, bleeding scores, and probing depth.
Radiographic measurements and standardized patient-reported questionnaires (food impaction and oral hygiene self-efficacy) will also be used.
The primary outcome is the reduction of plaque and gingival inflammatory scores at implant sites.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Siena, Italy, 53100
- AOUS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age between 18 and 70 years
- Presence of at least one implant loaded for ≥1 year
- Presence of bleeding (≥1 site or line/profuse bleeding) and/or suppuration on gentle probing around the implant
- Systemically healthy adults
- Able to provide written informed consent
Exclusion Criteria:
- Use of anticoagulants, anti-aggregants, antibiotics, or corticosteroids in the past 3 months
- Pregnant or lactating women
- Inability to perform adequate oral hygiene
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Superfloss
Participants in this group will receive an electronic toothbrush combined with Superfloss as the interproximal cleaning aid.
Personalized oral hygiene instructions and professional maintenance will be provided throughout the study.
|
Use of Superfloss daily as the interproximal cleaning device, combined with an electronic toothbrush, as part of a tailored oral hygiene protocol in patients with peri-implant disease.
|
|
Experimental: Interdental Brush
Participants in this group will receive an electronic toothbrush combined with interdental brushes for interproximal cleaning.
Tailored oral hygiene guidance and professional care will be offered during the follow-up visits.
|
Use of interdental brush once daily as the interproximal cleaning device, combined with an electronic toothbrush, within a professional oral hygiene maintenance program for peri-implant disease
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in plaque score at implant sites
Time Frame: through study completion, an average of 3 months
|
Change in plaque score at implant sites, recorded at four/six sites per implant using a standardized plaque index system.
|
through study completion, an average of 3 months
|
|
Change in bleeding score at implant sites
Time Frame: through study completion, an average of 3 months
|
Change in bleeding score at implant sites, recorded at four/six sites per implant using a standardized plaque index system.
|
through study completion, an average of 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 3, 2025
Primary Completion (Actual)
November 6, 2025
Study Completion (Actual)
November 6, 2025
Study Registration Dates
First Submitted
April 3, 2025
First Submitted That Met QC Criteria
April 10, 2025
First Posted (Actual)
April 11, 2025
Study Record Updates
Last Update Posted (Actual)
November 24, 2025
Last Update Submitted That Met QC Criteria
November 21, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INT001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
University of ManitobaUnknownPeri ImplantitisCanada
-
Istanbul Medipol University HospitalAnkara University; Ankara Medipol University; Lokman Hekim UniversityCompletedPeri Implantitis | Peri-Implant Health | Peri Implant MucositisTurkey (Türkiye)
-
King Abdullah University HospitalJordan University of Science and TechnologyCompletedPeri-Implantitis and Peri-implant MucositisJordan
-
University of PittsburghRecruiting
-
Research Centre for Medical Genetics, Russian FederationCompleted
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
Rambam Health Care CampusCompletedDental Implants,Peri-implantitis,SmokingIsrael
-
Recep Tayyip Erdogan UniversityNot yet recruitingPeri Implantitis | Peri Implant Mucositis
Clinical Trials on Superfloss
-
Shanghai Ninth People's Hospital Affiliated to...Recruiting
-
Riyadh Colleges of Dentistry and PharmacyUnknown
-
Universitat Internacional de CatalunyaCompleted